caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1235519638

Stacy CarstensenFNP

PRACTICEMYMICHIGAN MEDICAL CENTER CLARESee all providers at this practice →
Nurse PractitionerFarwell, MII
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (3)

CCN 237015
Home health agency
CCN 230180
Hospital
CCN 230222
Hospital
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
5,909
Beneficiaries
—
Total drug cost
$398K
Distinct drugs
110
Brand share
18.9%
Top prescribed drugs
Rosuvastatin Calcium292 claims
Levothyroxine Sodium257 claims
Amlodipine Besylate220 claims
Lisinopril216 claims
Losartan Potassium215 claims
REFERRAL NETWORK

Where Stacy Carstensen's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 3 outbound destinations.

Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
MYMICHIGAN MEDICAL CENTER CLARE46122
MYMICHIGAN MEDICAL CENTER CLARE34147
WERTHEIMER, MICHAEL1126
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.